The Malmo-Klaipeda WFH twinning programme: a comparative description of the haemophilia cohorts

Erik Berntorp, Jan Astermark, R Jurgutis, Stefan Lethagen, C Petersson

Research output: Contribution to journalReview articlepeer-review


In 1994, the Malmo-Klaipeda twinning programme was approved by the World Federation of Hemophilia. One of the first steps in the collaboration has been to set up a registry of the haemophilia patients in the Klaipeda area. In order to collect important clinical data the patients have been examined jointly by experts on haemophilia from the two centres. Seventeen out of 25 patients with severe haemophilia known at the Klaipeda centre were examined and compared to a matched cohort of patients from the Malmo centre. The main differences between the cohorts were that home treatment was not available to the Klaipeda patients, they received less treatment in general, had higher joint scores and more frequent bleeds. The pattern of transmission of blood-borne virus was very similar, with a high prevalence of hepatitis C antibodies. We conclude that the twinning programme between Malmo and Klaipeda has resulted in several achievements, including training of staff and a necessary inventory of the patients. This should not only form a suitable platform for the future development of haemophilia care in Lithuania, but could also serve as an example for liaisons between other haemophilia centres.
Original languageEnglish
Pages (from-to)79-82
Issue number2
Publication statusPublished - 1998

Bibliographical note

The information about affiliations in this record was updated in December 2015.
The record was previously connected to the following departments: Emergency medicine/Medicine/Surgery (013240200), Clinical Coagulation Research Unit (013242510)

Subject classification (UKÄ)

  • Hematology

Free keywords

  • arthropathy
  • factor VIII
  • factor IX
  • Haemophilia
  • joint score
  • prophylaxis


Dive into the research topics of 'The Malmo-Klaipeda WFH twinning programme: a comparative description of the haemophilia cohorts'. Together they form a unique fingerprint.

Cite this